Oncology and Hematology - Global Oncology Academy

561-573 of 573

The Use of TORS for HPV-Related Oropharynx Cancer
The Use of TORS for HPV-Related Oropharynx Cancer
Medical Breakthroughs from Penn Medicine
The Use of TORS for HPV-Related Oropharynx Cancer
- Lee Freedman, MD
Combatting Pancreatic Cancer: Keys to Early Recognition and Diagnosis
Combatting Pancreatic Cancer: Keys to Early Recognition and Diagnosis
Clinician's Roundtable
Combatting Pancreatic Cancer: Keys to Early Recognition and Diagnosis
- Ana Maria Rosario
The Most Common Pediatric Cancer: Acute Lymphoblastic Leukemia
The Most Common Pediatric Cancer: Acute Lymphoblastic Leukemia
Focus on Children's Health
The Most Common Pediatric Cancer: Acute Lymphoblastic Leukemia
- Bruce Bloom, DDS, JD
- Stephen Hunger, MD
Genetic Research into Hypodiploid ALL
Genetic Research into Hypodiploid ALL
Focus on Cancer
Genetic Research into Hypodiploid ALL
- Bruce Bloom, DDS, JD
- Charles Mullighan, MBBS, MSc, MD
An Emerging Vaccine Helps Prevent Prostate Cancer
An Emerging Vaccine Helps Prevent Prostate Cancer
Clinician's Roundtable
An Emerging Vaccine Helps Prevent Prostate Cancer
- Maurice Pickard, MD
- James L. Gulley, MD, PhD, FACP
Helping Cancer Patients with Quality of Life Issues Post Hysterectomy
Helping Cancer Patients with Quality of Life Issues Post Hysterectomy
Clinician's Roundtable
Helping Cancer Patients with Quality of Life Issues Post Hysterectomy
- Leslie P. Lundt, MD
- Lori Brotto, PhD
Using Testosterone for Refractory Prostate Cancer
Using Testosterone for Refractory Prostate Cancer
Clinician's Roundtable
Using Testosterone for Refractory Prostate Cancer
- Bruce Bloom, DDS, JD
- Walter Stadler, MD
Improving the Prognoses of Multiple Myeloma
Improving the Prognoses of Multiple Myeloma
Clinician's Roundtable
Improving the Prognoses of Multiple Myeloma
- Mark Nolan Hill, MD
- James Berenson, MD
Multiple Myeloma: Current Treatment Modalities
Multiple Myeloma: Current Treatment Modalities
Clinician's Roundtable
Multiple Myeloma: Current Treatment Modalities
- Mark Nolan Hill, MD
- James Berenson, MD
Prostate Cancer Predictability: Can We Anticipate a Patient's Risk in 25 Years?
Prostate Cancer Predictability: Can We Anticipate a Patient's Risk in 25 Years?
Clinician's Roundtable
Prostate Cancer Predictability: Can We Anticipate a Patient's Risk in 25 Years?
- Bill Rutenberg, MD
- Andrew Vickers, PhD
The Environmental Etiologies of Multiple Myeloma
The Environmental Etiologies of Multiple Myeloma
Clinician's Roundtable
The Environmental Etiologies of Multiple Myeloma
- Shira Johnson, MD
- Brian Durie, MD
New Treatments for Multiple Myeloma
New Treatments for Multiple Myeloma
Clinician's Roundtable
New Treatments for Multiple Myeloma
- Shira Johnson, MD
- Brian Durie, MD
Endometrial Cancer
Endometrial Cancer
Clinician's Roundtable
Endometrial Cancer
- Joel Heller, MD
- Diljeet Singh, MD

Previous
1
2
…
34
35
36
Next

36/6